Tanios Bekaii-Saab, MD: Mutations in Colorectal Cancer

preview_player
Показать описание
  1. Targeted Oncology
  2. targeted oncology
  3. oncology
  4. cancer
Рекомендации по теме
Tanios Bekaii-Saab, MD: 0:01:27

Tanios Bekaii-Saab, MD: Mutations in Colorectal Cancer

Tanios Bekaii-Saab, MD: 0:00:26

Tanios Bekaii-Saab, MD: RAS Mutations in Metastatic Colorectal Cancer

Tanios Bekaii-Saab, MD: 0:01:59

Tanios Bekaii-Saab, MD: Impeding RAS Mutation Testing

Tanios Bekaii-Saab, MD: 0:01:14

Tanios Bekaii-Saab, MD: Clinical Importance of RAS Mutations

Tanios S. Bekaii-Saab, 0:26:46

Tanios S. Bekaii-Saab, MD, on Next-Generation Sequencing for Gastrointestinal Cancer

Tanios Bekaii Saab, 0:05:08

Tanios Bekaii Saab, MD: RAS Mutations and the Sequence of Therapies

Tanios Bekaii-Saab, MD: 0:00:31

Tanios Bekaii-Saab, MD: Percentage of RAS Mutation Tests in Metastatic CRC

Emerging Role of 0:32:21

Emerging Role of HER2-Targeted Therapy in BTCs — Tanios Bekaii-Saab, MD

Tanios Bekaii Saab, 0:02:56

Tanios Bekaii Saab, MD: Treatment Toxicities and Quality of Life

All Patients With 0:00:46

All Patients With GI Cancers Should Undergo NGS

Tanios Bekaii-Saab, MD: 0:00:36

Tanios Bekaii-Saab, MD: KRAS Status in mCRC

Tanios Bekali-Saab, MD, 0:00:57

Tanios Bekali-Saab, MD, tells us whether KRAS is a definitive biomarker in mCRC patients

Tanios Bekaii-Saab, MD: 0:02:17

Tanios Bekaii-Saab, MD: First-Line Treatments in Unresectable Colon Cancer

Dr Bekaii-Saab on 0:01:45

Dr Bekaii-Saab on Frontline Treatment Considerations for BRCA1/2+ Pancreatic Cancer

Tanios Bekaii-Saab, MD, 0:04:39

Tanios Bekaii-Saab, MD, FACP, offers opinion on the updated KEYNOTE-177 as presented at ASCO GI 2021

Mutation Analysis in 0:05:14

Mutation Analysis in Colorectal Cancer

Tanios Bekaii-Saab MD, 0:03:29

Tanios Bekaii-Saab MD, FACP, considers the emerging role of immunotherapy in advanced CRC treatment

Germline Genomic Syndromes... 0:36:43

Germline Genomic Syndromes... (D2P8)

Tanios Bekaii-Saab, MD 0:00:51

Tanios Bekaii-Saab, MD on outcomes of CALGB/SWOG 80404 and potential impact

Tanios Bekaii-Saab MD, 0:03:31

Tanios Bekaii-Saab MD, FACP describes deintensification strategies for mCRC patients during COVID-19

Tanios Bekaii-Saab, MD: 0:00:44

Tanios Bekaii-Saab, MD: Fourth-Line Therapy in mCRC

Understanding Tumor Sidedness 0:10:06

Understanding Tumor Sidedness in Colorectal Cancer

Dr. Bekaii Saab 0:01:33

Dr. Bekaii Saab on the Expansion of Treatment Options in Colorectal Cancer

Treatment for RAS-mutated 0:03:08

Treatment for RAS-mutated mCRC